Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ayesha Murtuza
Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer
Cancer Research
Cancer Research
Oncology
Related publications
P1.13-10 Aurora Kinase a Drives the Evolution of Resistance to Third Generation EGFR Inhibitors in Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Intrinsic Resistance to EGFR Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer With Activating EGFR Mutations
OncoTargets and Therapy
Oncology
Pharmacology
EGFR Tyrosine Kinase Inhibitors in Lung Cancer: Make No Assumptions
Current Oncology
Oncology
EGFR Tyrosine Kinase Inhibitors in Lung Cancer: Make No Assumptions
Current Oncology
Oncology
WZ4002, a Third-Generation EGFR Inhibitor, Can Overcome Anoikis Resistance in EGFR-mutant Lung Adenocarcinomas More Efficiently Than SRC Inhibitors
Laboratory Investigation
Forensic Medicine
Pathology
Cell Biology
Molecular Biology
Transporter and Lysosomal Mediated (Multi)drug Resistance to Tyrosine Kinase Inhibitors and Potential Strategies to Overcome Resistance
Cancers
Cancer Research
Oncology
HGF Induces Novel EGFR Functions Involved in Resistance Formation to Tyrosine Kinase Inhibitors
Oncogene
Cancer Research
Genetics
Molecular Biology
Glucosylated Epigallocatechin Gallate (EGCG) Derivatives Combined With EGFR Tyrosine Kinase Inhibitor Overcome Resistance in EGFR T790M Mutant Lung Cancer
Biomedical Journal of Scientific & Technical Research
ALK, ROS1 and EGFR Next-Generation Tyrosine Kinase Inhibitors in Advanced Non-Small-Cell Lung Cancer
Oncology in Clinical Practice
Oncology
